Showing results (131-140 of 969) with videos related to
Sort By:
Pageof 97
Expert Review of Hematology|August 12, 2017
Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199Kiran Naqvi, Marina Konopleva, Farhad RavandiCancer Journal (Sudbury, Mass.)|April 25, 2006
Novel agents in acute myeloid leukemiaAhmed Aribi, Farhad Ravandi, Frank GilesLeukemia & Lymphoma|December 19, 2009
Advances in treatment of chronic myelogenous leukemia--new treatment options with tyrosine kinase inhibitorsFabio P S Santos, Farhad RavandiCurrent Treatment Options in Oncology|March 22, 2014
Update on the biology and treatment options for hairy cell leukemiaPreetesh Jain, Naveen Pemmaraju, Farhad RavandiLeukemia & Lymphoma|January 8, 2015
Novel therapeutic options for relapsed hairy cell leukemiaPreetesh Jain, Aaron Polliack, Farhad RavandiExpert Review of Anticancer Therapy|June 20, 2020
Identifying effective drug combinations for patients with acute myeloid leukemiaMusa Yilmaz, Tapan Kadia, Farhad RavandiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignanciesFarhad Ravandi, Moshe Talpaz, Zeev EstrovLeukemia|May 6, 2021
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developmentsNaval Daver, Ahmad S Alotaibi, Veit Bücklein, et al.Clinical Lymphoma, Myeloma & Leukemia|January 30, 2015
Characteristics of Sweet Syndrome in patients with acute myeloid leukemiaSyed M Kazmi, Naveen Pemmaraju, Keyur P Patel, et al.Blood Advances|August 16, 2022
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndromeCourtney D DiNardo, Sangeetha Venugopal, Curtis Lachowiez, et al.Pageof 97